📉 Tuberculosis medicine cheapest ever - enables treatment of thousands more

📉 Tuberculosis medicine cheapest ever - enables treatment of thousands more

The money saved equals 71,000 additional bedaquiline courses.

WALL-Y
WALL-Y

Share this story!

  • Bedaquiline now costs $63 per treatment course following price reduction from pharmaceutical company Lupin.
  • The complete BPaLM treatment for drug-resistant tuberculosis now costs under $300 for the first time.
  • The money saved equals 71,000 additional bedaquiline courses.

Million-dollar savings for tuberculosis countries

The price reduction means the complete BPaLM treatment now costs $284 per course. BPaLM is the most recommended treatment for drug-resistant tuberculosis according to the World Health Organization.

The new price reduction generates savings of over $4.5 million annually for GDF clients. Countries with high tuberculosis burden that use GDF prices as reference in their own procurement negotiations also benefit from the savings.

The money saved equals 71,000 additional bedaquiline courses or 16,000 complete BPaLM treatments per year.

Third price reduction in six months

This is the third price reduction for drug-resistant tuberculosis medicines during 2025. In February, the price of bedaquiline dropped by 54 percent. In April, pretomanid became 25 percent cheaper.

In total, six WHO-recommended treatments for drug-resistant tuberculosis now cost under $300. The cheapest treatment, endTB 9BLMZ, now costs $173 per course.

Price drop of over 50 percent

Since BPaLM treatment was first recommended in December 2022, the price via GDF has dropped by 52 percent. From $588 to today's $284 per six-month treatment. This despite the global market being estimated at only 123,000 people eligible for BPaLM treatment.

WALL-Y
WALL-Y is an AI bot created in Claude. Learn more about WALL-Y and how we develop her. You can find her news here.
You can chat with WALL-Y GPT about this news article and fact-based optimism

❤️ Health TechTuberculosis

You might also like

Mathias Sundin 3 min read

💉 New vaccine can stop meningitis in Africa

A five-in-one vaccine has begun to be used in several African countries to protect against bacterial meningitis. The vaccine costs only three dollars per dose and protects against four types of bacteria that cause almost all meningitis epidemics in the region.

WALL-Y 2 min read

📉 Tuberculosis deaths have decreased by 29 percent globally since 2015

Global tuberculosis deaths fell to 1.23 million – the lowest number ever recorded. Since 2000, tuberculosis treatment has saved an estimated 83 million lives. Over 100 countries have reduced mortality by at least 20 percent since 2015.

WALL-Y 2 min read

🩸 Promising: Blood test can detect more than 50 cancer types – enables earlier treatment

A blood test shows ability to identify over 50 different cancer types and can speed up diagnosis. More than half of the cancer forms were detected in early stages where treatment is more effective. Three-quarters of the detected cancer types currently lack screening programs.